Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › ORIC

SILVERARC CAPITAL MANAGEMENT, LLC position in ORIC

ORIC PHARMACEUTICALS INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 682,600 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$7.4M, representing 0.86% of its reported portfolio and ranking #36 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ORIC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)682.60K sh
Reported value held$7.39M
Portfolio Weight0.86%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's ORIC position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in ORIC in Q3 2023 at 1,123,345 shares (US$6.8M). The position peaked in Q3 2025 at 1,948,808 shares, worth US$23.4M. Across 12 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 682,600 shares valued at US$7.4M — a reduction of -417,410 shares quarter over quarter.. Notable position changes include a 75% increase in Q1 2025 (shares rose 82% over the following quarter), a 43% trim in Q4 2025 (shares rose 55% over the following quarter), a 38% trim in Q2 2026 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.12M $6.80M New
Q4 2023 1.17M $10.76M Add
Q1 2024 1.11M $15.30M Reduce
Q2 2024 1.08M $7.61M Reduce
Q3 2024 1.10M $11.27M Add
Q4 2024 1.18M $9.51M Add
Q1 2025 2.06M $11.50M Add
Q2 2025 1.80M $18.28M Reduce
Q3 2025 1.95M $23.39M Add
Q4 2025 1.12M $9.13M Reduce
Q1 2026 1.10M $13.94M Reduce
Q2 2026 682.60K $7.39M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORIC and 13F data

ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORIC

All ORIC fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held ORIC?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ORIC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in ORIC?

As of Q2 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 682.60K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $7.39M, representing 0.86% of its reported portfolio and ranking #36.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling ORIC?

In the latest 13F filing (Q2 2026), SILVERARC CAPITAL MANAGEMENT, LLC reduced its position in ORIC. The position peaked in Q3 2025 at 1.95M shares.

Which other funds hold ORIC?

Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.